(-)-demecolcine decreases expression ISO RGD:735785 6480464 Demecolcine results in decreased expression of TMPO mRNA CTD PMID:23649840 1,1-dichloroethene increases expression ISO RGD:11425 6480464 vinylidene chloride results in increased expression of TMPO mRNA CTD PMID:26682919 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of TMPO protein CTD PMID:17337753 1,2-dichloroethane increases expression ISO RGD:11425 6480464 ethylene dichloride results in increased expression of TMPO mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:11425 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPO mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:735785 6480464 Dinitrochlorobenzene binds to TMPO protein CTD PMID:32991956 1-nitropyrene increases expression ISO RGD:735785 6480464 1-nitropyrene results in increased expression of TMPO mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression ISO RGD:11425 6480464 Ethinyl Estradiol results in increased expression of TMPO mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:11425 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPO mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:735785 6480464 Estradiol results in increased expression of TMPO mRNA CTD PMID:16474171 more ... 17beta-estradiol multiple interactions ISO RGD:11425 6480464 [Polyphenols co-treated with Estradiol] results in decreased expression of TMPO mRNA CTD PMID:30077407 17beta-estradiol decreases expression ISO RGD:11425 6480464 Estradiol results in decreased expression of TMPO mRNA CTD PMID:30077407 17beta-estradiol decreases phosphorylation ISO RGD:735785 6480464 Estradiol results in decreased phosphorylation of TMPO protein CTD PMID:27026707 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11425 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPO mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TMPO mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TMPO mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11425 6480464 Tetrachlorodibenzodioxin affects the expression of TMPO mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11425 6480464 Tetrachlorodibenzodioxin results in decreased expression of TMPO mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11425 6480464 Tetrachlorodibenzodioxin results in increased expression of TMPO mRNA CTD PMID:15328365 , PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of TMPO mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:11425 6480464 Fenretinide results in increased expression of TMPO mRNA CTD PMID:28973697 4-phenylbutyric acid decreases expression ISO RGD:735785 6480464 4-phenylbutyric acid results in decreased expression of TMPO mRNA CTD PMID:14583596 5-azacytidine multiple interactions ISO RGD:735785 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of TMPO mRNA CTD PMID:18720364 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 aconitine increases expression EXP 6480464 Aconitine results in increased expression of TMPO protein CTD PMID:33236894 afimoxifene decreases expression ISO RGD:735785 6480464 afimoxifene results in decreased expression of TMPO mRNA CTD PMID:16514628 all-trans-retinoic acid decreases expression ISO RGD:735785 6480464 Tretinoin results in decreased expression of TMPO mRNA CTD PMID:15498508 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TMPO mRNA CTD PMID:16483693 aristolochic acid decreases expression ISO RGD:735785 6480464 aristolochic acid I results in decreased expression of TMPO mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:11425 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of TMPO mRNA CTD PMID:23650126 arsenite(3-) affects expression ISO RGD:735785 6480464 arsenite affects the expression of TMPO mRNA CTD PMID:22959463 arsenous acid increases expression ISO RGD:735785 6480464 Arsenic Trioxide results in increased expression of TMPO mRNA CTD PMID:20458559 arsenous acid decreases expression ISO RGD:735785 6480464 Arsenic Trioxide results in decreased expression of TMPO mRNA CTD PMID:26705709 azathioprine decreases expression ISO RGD:735785 6480464 Azathioprine results in decreased expression of TMPO mRNA CTD PMID:22623647 benzatropine decreases expression ISO RGD:735785 6480464 Benztropine results in decreased expression of TMPO protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:735785 6480464 Benzo(a)pyrene results in decreased expression of TMPO mRNA, Benzo(a)pyrene results in decreased expression of TMPO protein CTD PMID:20097212 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735785 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:735785 6480464 Mustard Gas results in increased phosphorylation of TMPO protein CTD PMID:19845377 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TMPO promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:735785 6480464 bisphenol A results in increased expression of TMPO mRNA CTD PMID:16474171 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TMPO mRNA CTD PMID:34947998 bisphenol A affects expression ISO RGD:735785 6480464 bisphenol A affects the expression of TMPO mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:735785 6480464 bisphenol A results in decreased expression of TMPO mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TMPO mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TMPO promoter CTD PMID:23359474 bortezomib decreases expression ISO RGD:735785 6480464 Bortezomib results in decreased expression of TMPO mRNA CTD PMID:20977926 cadmium dichloride decreases expression ISO RGD:735785 6480464 Cadmium Chloride results in decreased expression of TMPO protein CTD PMID:24527689 calcitriol decreases expression ISO RGD:735785 6480464 Calcitriol results in decreased expression of TMPO mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:735785 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TMPO mRNA CTD PMID:21592394 cisplatin multiple interactions ISO RGD:735785 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of TMPO mRNA] CTD PMID:21858171 clozapine decreases expression ISO RGD:735785 6480464 Clozapine results in decreased expression of TMPO protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:735785 6480464 cobaltous chloride results in decreased expression of TMPO mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TMPO mRNA CTD PMID:24386269 cocaine increases expression EXP 6480464 Cocaine results in increased expression of TMPO mRNA CTD PMID:17898221 copper atom multiple interactions ISO RGD:735785 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TMPO mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:735785 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TMPO mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:735785 6480464 Copper Sulfate results in decreased expression of TMPO mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:735785 6480464 Coumestrol results in increased expression of TMPO mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:735785 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:11425 6480464 Asbestos, Crocidolite results in decreased expression of TMPO mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:735785 6480464 Cyclosporine results in decreased expression of TMPO mRNA CTD PMID:20106945 more ... deoxynivalenol affects phosphorylation ISO RGD:11425 6480464 deoxynivalenol affects the phosphorylation of TMPO protein CTD PMID:23811945 diarsenic trioxide increases expression ISO RGD:735785 6480464 Arsenic Trioxide results in increased expression of TMPO mRNA CTD PMID:20458559 diarsenic trioxide decreases expression ISO RGD:735785 6480464 Arsenic Trioxide results in decreased expression of TMPO mRNA CTD PMID:26705709 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of TMPO mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TMPO promoter CTD PMID:23359474 disodium selenite decreases expression ISO RGD:735785 6480464 Sodium Selenite results in decreased expression of TMPO mRNA CTD PMID:24383545 diuron decreases expression EXP 6480464 Diuron results in decreased expression of TMPO mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:735785 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:735785 6480464 TMPO protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:735785 6480464 Doxorubicin results in decreased expression of TMPO mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:735785 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:735785 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TMPO protein CTD PMID:23301498 ethyl methanesulfonate decreases expression ISO RGD:735785 6480464 Ethyl Methanesulfonate results in decreased expression of TMPO mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of TMPO mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of TMPO mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:11425 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPO mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:735785 6480464 Formaldehyde results in decreased expression of TMPO mRNA CTD PMID:23649840 fulvestrant decreases expression ISO RGD:735785 6480464 fulvestrant results in decreased expression of TMPO mRNA CTD PMID:16514628 genistein increases expression ISO RGD:735785 6480464 Genistein results in increased expression of TMPO mRNA CTD PMID:16474171 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TMPO mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of TMPO mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of TMPO mRNA CTD PMID:24136188 hydrogen peroxide decreases expression ISO RGD:735785 6480464 Hydrogen Peroxide results in decreased expression of TMPO mRNA CTD PMID:12414654 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 ivermectin decreases expression ISO RGD:735785 6480464 Ivermectin results in decreased expression of TMPO protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of TMPO mRNA CTD PMID:20080153 lead(0) affects expression ISO RGD:735785 6480464 Lead affects the expression of TMPO mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:735785 6480464 Lead affects the expression of TMPO mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:735785 6480464 leflunomide results in decreased expression of TMPO mRNA CTD PMID:28988120 menadione decreases expression ISO RGD:735785 6480464 Vitamin K 3 results in decreased expression of TMPO mRNA CTD PMID:12414654 methyl methanesulfonate increases expression ISO RGD:735785 6480464 Methyl Methanesulfonate results in increased expression of TMPO mRNA CTD PMID:23649840 methyl methanesulfonate decreases expression ISO RGD:735785 6480464 Methyl Methanesulfonate results in decreased expression of TMPO mRNA CTD PMID:23649840 methylparaben decreases expression ISO RGD:735785 6480464 methylparaben results in decreased expression of TMPO mRNA CTD PMID:31745603 N-nitrosodiethylamine multiple interactions ISO RGD:11425 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TMPO mRNA] CTD PMID:17854601 N-nitrosodiethylamine increases expression ISO RGD:11425 6480464 Diethylnitrosamine results in increased expression of TMPO mRNA CTD PMID:17854601 nickel atom decreases expression ISO RGD:11425 6480464 Nickel results in decreased expression of TMPO mRNA CTD PMID:18922574 nickel dichloride decreases expression ISO RGD:735785 6480464 nickel chloride results in decreased expression of TMPO mRNA CTD PMID:17312168 nitroglycerin increases expression EXP 6480464 Nitroglycerin results in increased expression of TMPO mRNA CTD PMID:12102619 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TMPO mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of TMPO mRNA CTD PMID:25729387 palbociclib decreases expression ISO RGD:735785 6480464 palbociclib results in decreased expression of TMPO mRNA CTD PMID:22869556 paracetamol decreases expression ISO RGD:735785 6480464 Acetaminophen results in decreased expression of TMPO mRNA CTD PMID:21420995 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TMPO mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO RGD:11425 6480464 Pentachlorophenol results in increased expression of TMPO mRNA CTD PMID:23892564 perfluorononanoic acid decreases expression ISO RGD:735785 6480464 perfluoro-n-nonanoic acid results in decreased expression of TMPO mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO RGD:735785 6480464 perfluorooctanoic acid results in decreased expression of TMPO protein CTD PMID:26879310 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of TMPO mRNA CTD PMID:17616710 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of TMPO mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:11425 6480464 Phenobarbital affects the expression of TMPO mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:735785 6480464 Phenylmercuric Acetate results in decreased expression of TMPO mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735785 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMPO mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:11425 6480464 pirinixic acid results in decreased expression of TMPO mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:11425 6480464 pirinixic acid results in increased expression of TMPO mRNA CTD PMID:23811191 piroxicam multiple interactions ISO RGD:735785 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of TMPO mRNA] CTD PMID:21858171 piroxicam increases expression ISO RGD:735785 6480464 Piroxicam results in increased expression of TMPO mRNA CTD PMID:21858171 potassium dichromate decreases expression ISO RGD:11425 6480464 Potassium Dichromate results in decreased expression of TMPO mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of TMPO mRNA CTD PMID:19162173 progesterone affects expression ISO RGD:11425 6480464 Progesterone affects the expression of TMPO mRNA CTD PMID:17251523 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of TMPO mRNA CTD PMID:20726854 propanal decreases expression ISO RGD:735785 6480464 propionaldehyde results in decreased expression of TMPO mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:11425 6480464 propiconazole results in increased expression of TMPO mRNA CTD PMID:19363144 , PMID:21278054 raloxifene decreases expression ISO RGD:735785 6480464 Raloxifene Hydrochloride results in decreased expression of TMPO mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:735785 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of TMPO mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of TMPO mRNA CTD PMID:19167446 , PMID:23557933 resveratrol decreases expression ISO RGD:11425 6480464 resveratrol results in decreased expression of TMPO protein CTD PMID:25505154 resveratrol decreases phosphorylation ISO RGD:735785 6480464 resveratrol results in decreased phosphorylation of TMPO protein CTD PMID:25311616 SB 431542 multiple interactions ISO RGD:735785 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:11425 6480464 sodium arsenite results in decreased expression of TMPO mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:735785 6480464 sodium arsenite results in increased expression of TMPO mRNA CTD PMID:29301061 , PMID:34032870 sodium arsenite affects methylation ISO RGD:735785 6480464 sodium arsenite affects the methylation of TMPO gene CTD PMID:28589171 sodium fluoride decreases expression ISO RGD:11425 6480464 Sodium Fluoride results in decreased expression of TMPO protein CTD PMID:28918527 sodium fluoride increases expression ISO RGD:11425 6480464 Sodium Fluoride results in increased expression of TMPO protein CTD PMID:27548804 succimer multiple interactions ISO RGD:11425 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMPO mRNA CTD PMID:21641980 sulindac sulfide decreases expression ISO RGD:735785 6480464 sulindac sulfide results in decreased expression of TMPO mRNA CTD PMID:16184548 tamibarotene affects expression ISO RGD:735785 6480464 tamibarotene affects the expression of TMPO mRNA CTD PMID:15498508 temozolomide increases expression ISO RGD:735785 6480464 Temozolomide results in increased expression of TMPO mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:735785 6480464 tert-Butylhydroperoxide results in decreased expression of TMPO mRNA CTD PMID:12414654 , PMID:15336504 testosterone multiple interactions ISO RGD:735785 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TMPO mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:735785 6480464 Testosterone results in decreased expression of TMPO mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:11425 6480464 Carbon Tetrachloride results in increased expression of TMPO mRNA CTD PMID:31919559 thalidomide multiple interactions ISO RGD:735785 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of TMPO mRNA CTD PMID:18720364 titanium dioxide decreases expression ISO RGD:11425 6480464 titanium dioxide results in decreased expression of TMPO mRNA CTD PMID:29264374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of TMPO mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TMPO mRNA CTD PMID:25729387 tremolite asbestos increases expression ISO RGD:11425 6480464 tremolite results in increased expression of TMPO mRNA CTD PMID:29279043 triadimefon increases expression ISO RGD:11425 6480464 triadimefon results in increased expression of TMPO mRNA CTD PMID:19363144 Tributyltin oxide decreases phosphorylation ISO RGD:11425 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of TMPO protein CTD PMID:22174045 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of TMPO mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:735785 6480464 trichostatin A results in decreased expression of TMPO mRNA CTD PMID:26272509 trichostatin A affects expression ISO RGD:735785 6480464 trichostatin A affects the expression of TMPO mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:735785 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMPO mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:11425 6480464 trimellitic anhydride results in increased expression of TMPO mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:11425 6480464 triptonide results in increased expression of TMPO mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:11425 6480464 troglitazone results in decreased expression of TMPO mRNA CTD PMID:28973697 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of TMPO mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:11425 6480464 Valproic Acid results in decreased expression of TMPO mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:735785 6480464 Valproic Acid results in decreased expression of TMPO mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:735785 6480464 Valproic Acid results in decreased methylation of TMPO gene CTD PMID:29154799 valproic acid affects expression ISO RGD:735785 6480464 Valproic Acid affects the expression of TMPO mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:735785 6480464 Valproic Acid results in increased expression of TMPO mRNA CTD PMID:29154799 vincaleukoblastine affects response to substance ISO RGD:735785 6480464 TMPO protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TMPO mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:735785 6480464 vorinostat results in decreased expression of TMPO mRNA CTD PMID:22083351